Evidence map›Paper›PMID 22539955›Full record

ArticlePloS one2012

Streptococcus pneumoniae carriage in the Gaza strip.

Gili Regev-Yochay, Izzeldin Abullaish, Richard Malley, Bracha Shainberg, Miriam Varon, Yulia Roytman, Arnona Ziv, Aviva Goral, Abedallah Elhamdany, Galia Rahav and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03064620 (PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study), which is not on this map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03064620 unknown statusnot on this mapstarted 2014, after this paper: background citation

PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study

TypeobservationalSponsorSheba Medical CenterRan2014 to 2022Enrolled12,800ConditionsStreptococcus PneumoniaeArmsPCV
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Gili Regev-YochayInfectious Disease Unit, Sheba Medical Center, Tel-Hashomer affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. gregev@hsph.harvard.edu
Izzeldin Abullaish
Richard Malley
Bracha Shainberg
Miriam Varon
Yulia Roytman
Arnona Ziv
Aviva Goral
Abedallah Elhamdany
Galia Rahav
Meir Raz
Palestinian-Israeli Collaborative Research Study Group
Israel National Institute for Health Policy Research · ILMaccabi Health Care Services · ILTel Aviv University · ILBoston Children's Hospital · USPublic Health Ontario · CA

Funding

Mechanisms of Immunity to Pneumococcal ColonizationR01AI066013 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI MALLEY, RICHARD · 2007 to 2011
$2.1M
CCR NIH HHS RC-24010NIAID NIH HHS R01 AI066013
6 · The paper itself

Abstract

backgroundPneumococcal infections cause major morbidity and mortality in developing countries. We report the epidemiology of S. pneumoniae carriage in a developing region, the Gaza strip, and evaluate the theoretical coverage of carriage strains by pneumococcal conjugate vaccines (PCVs). METHODOLOGY: In 2009 we conducted a cross-sectional survey of S. pneumoniae carriage in healthy children and their parents, living throughout the Gaza strip. Data were collected and nasopharyngeal swabs were obtained. Antibiotic susceptibilities were determined by Vitek-2 and serotypes by the Quellung reaction. PRINCIPAL

findingsS. pneumoniae carriage was detected in 189/379 (50%) of children and 30/376 (8%) of parents. Carriage prevalence was highest in children <6 months of age (63%). Significant predictors for child carriage were number of household members and DCC attendance. The proportion of pediatric and adults isolates with serotypes included in PCV7 were 32% and 20% respectively, and 46% and 33% in PCV13 respectively. The most prominent non-vaccine serotypes (NVT) were 35B, 15B/C and 23B. Penicillin-nonsusceptible strains were carried by 70% of carriers, penicillin-resistant strains (PRSP) by 13% and Multi-drug-resistant (MDR) by 30%. Of all PRSP isolates 54% belonged to serotypes included in PCV7 and 71% in the PCV13. Similarly, 59% and 73% of MDR-SP isolates, would theoretically be covered by PCV7 and PCV13, respectively.

conclusionsThis study demonstrates that, PCV13-included strains were carried by 46% and 33% of pediatric and adult subjects respectively. In the absence of definitive data regarding the virulence of the NVT strains, it is difficult to predict the effect of PCVs on IPD in this region.

Indexed as

AdultAnti-Bacterial AgentsChildChild, PreschoolCross-Sectional StudiesDrug Resistance, Multiple, BacterialFemaleHumansInfantMaleMiddle EastNasopharynxPenicillinsPneumococcal InfectionsSerotypingStreptococcus pneumoniaeAnti-Bacterial AgentsPenicillins

Identifiers

PMID22539955
PMCPMC3335158
OpenAlexW2163723567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.